PE-22-28 is a peptide therapy that targets the TREK-1 channel to enhance mood, cognitive function, and neurogenesis, offering rapid and effective depression management with minimal side effects.
$285.00
PE-22-28 is a peptide therapy designed to support mood regulation, cognitive function, and depression management. Derived from Spadin, a naturally occurring protein, PE-22-28 works by inhibiting the TREK-1 channel, a critical pathway in the brain associated with mood, memory, and learning. By targeting this receptor, PE-22-28 promotes rapid neurogenesis and enhances mental well-being with fewer side effects compared to traditional antidepressants.
Key Benefits: